SubHero Banner
Text

Bionpharma – Recall of clobazam oral suspension

July 31, 2019 - The FDA enforcement report announced a class II, patient-level recall of one lot of Bionpharma’s clobazam oral suspension due to microbial contamination.

Download PDF